Guru Ownership Trend
Guru Analysis for CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $41.33 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $5.09 M net inflow during the quarter.
Recent activity highlights Jefferies Group who dramatically increased their stake. Conversely, Steven Cohen reduced exposure by 0.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for CytomX Therapeutics, Inc. (CTMX)
Major holders include Steven Cohen ($29.29 M), Jefferies Group ($14.42 M), Paul Tudor Jones ($5.18 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 12.3 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.09 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CTMX. The total reported sell value was $241,338.75.
Yes, 2 managers opened new positions in CTMX, and 0 increased their existing holdings. The total reported buy value was $5.34 M.